Dopamine receptors and hypertension

Current Hypertension Reports

Volumn 10, Issue 4, 2008, Pages 268-275

  Banday, Anees Ahmad ^a   Lokhandwala, Mustafa F ^b  

^a UNIVERSITY OF HOUSTON   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

1 [[6 (3 METHOXYESTRA 1,3,5(10) TRIEN 17BETA YL)AMINO]HEXYL] 1H PYRROLE 2,5 DIONE; 2,3,4,5 TETRAHYDRO 8 IODO 3 METHYL 5 PHENYL 1H 3 BENZAZEPIN 7 OL; 8 CHLORO 2,3,4,5 TETRAHYDRO 3 METHYL 5 PHENYL 1H 3 BENZAZEPIN 7 OL HYDROGEN MALEATE; ADENOSINE TRIPHOSPHATASE (POTASSIUM SODIUM); ADENYLATE CYCLASE; APOCYNIN; BENSERAZIDE; CARBIDOPA; CELL SURFACE RECEPTOR; CHOLERA TOXIN; DOPAMINE; DOPAMINE 1 RECEPTOR; DOPAMINE 2 RECEPTOR; DOPAMINE 3 RECEPTOR; DOPAMINE 4 RECEPTOR; DOPAMINE 5 RECEPTOR; DOPAMINE RECEPTOR; DOPAMINE RECEPTOR STIMULATING AGENT; FENOLDOPAM; FORSKOLIN; GUANINE NUCLEOTIDE BINDING PROTEIN; RECEPTOR SUBTYPE; SODIUM PROTON EXCHANGE PROTEIN; CARDIOTONIC AGENT;

ANTIOXIDANT ACTIVITY; BLOOD PRESSURE REGULATION; DAHL SALT SENSITIVE RAT; DOPAMINE METABOLISM; DOPAMINERGIC SYSTEM; DRUG MECHANISM; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME INHIBITION; ESSENTIAL HYPERTENSION; GENETIC MODEL; HUMAN; HYPERTENSION; KIDNEY FUNCTION; KIDNEY PROXIMAL TUBULE; KIDNEY TUBULE ABSORPTION; LOW DRUG DOSE; MAMMAL; MOLECULAR CLONING; NONHUMAN; OXIDATIVE STRESS; PROTEIN FUNCTION; PROTEIN PROCESSING; PROTON SODIUM EXCHANGE; RECEPTOR BINDING; REVIEW; SALT LOADING; SIGNAL TRANSDUCTION; SODIUM ABSORPTION; SODIUM URINE LEVEL; SPONTANEOUSLY HYPERTENSIVE RAT; ANIMAL; DRUG EFFECT; KIDNEY; NATRIURESIS; PATHOPHYSIOLOGY; PHYSIOLOGY; URINE;

ANIMALS; CARDIOTONIC AGENTS; DOPAMINE; HUMANS; HYPERTENSION; KIDNEY; NATRIURESIS; OXIDATIVE STRESS; RECEPTORS, DOPAMINE; SIGNAL TRANSDUCTION;

EID: 52449086193     PISSN: 15226417     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11906-008-0051-9     Document Type: Review

References (50)

1. Jose PA, Raymond JR, Bates MD, et al.: The renal dopamine receptors. J Am Soc Nepbrol 1992, 2:1265-1278.
2. Yoshimura M, Ikegaki I, Nishimura M, Takahashi H: Role of dopaminergic mechanisms in the kidney for the pathogenesis of hypertension. J Anton Pharmacol 1990, 10(Suppl 1):S67-S72.
3. Hussain T, Lokhandwala MF: Renal dopamine DA1 receptor coupling with G(S) and G(q/11) proteins in spontaneously hypertensive rats. Am J Physiol 1997, 272:F339-346.
4. Albrecht FE, Drago J, Felder RA, et al.: Role of the D1A dopamine receptor in the pathogenesis of genetic hypertension. J Clin Invest 1996, 97:2283-2288.
5. Zeng C, Armando I, Luo Y, et al.: Dysregulation of dopamine-dependent mechanisms as a determinant of hypertension: studies in dopamine receptor knockout mice. Am J Physiol Heart Circ Physiol 2008, 294:H551-H569.
6. Missale C, Nash SR, Robinson SW, et al.: Dopamine receptors: from structure to function. Physiol Rev 1998, 78:189-225.
7. Lokhandwala MF, Amenta F: Anatomical distribution and function of dopamine receptors in the kidney. Faseb J 1991, 5:3023-3030.
8. Goldberg LI: Cardiovascular and renal actions of dopamine: potential clinical applications. Pharmacol Rev 1972, 24:1-29.
9. Frederickson ED, Bradley T, Goldberg LI: Blockade of renal effects of dopamine in the dog by the DA1 antagonist SCH 23390. Am J Physiol 1985, 249:F236-F240.
10. Hahn RA, Wardell JR Jr: Renal vascular activity of SK&F 38393 and dopamine in anesthetized dogs. J Cardiovasc Pharmacol 2:583-593, 1980.
11. Hussain T, Lokhandwala MF: Renal dopamine receptors and hypertension. Exp Biol Med (Maywood) 228:134-142, 2003.
12. Hedge SS, Ricci A, Amenta F, Lokhandwala MF: Evidence from functional and autoradiographic studies for the presence of tubular dopamine-1 receptors and their involvement in the renal effects of fenoldopam. J Pharmacol Exp Ther 1989, 251:1237-1245.
13. Romero-Vecchione E, Vasquez J, Lema G, et al.: Low urinary dopamine excretion associated to low sodium excretion in normotensive Piaroa Amazonian ethnia compared to urban subjects. Invest Clin 1995, 36:61-71.
14. Chen CJ, Lokhandwala MF: Role of endogenous dopamine in the natriuretic response to various degrees of iso-osmotic volume expansion in rats. Clin Exp Hypertens A 1991, 13:1117-1126.
15. Hegde SS, Jadhav AL, Lokhandwala MF: Role of kidney dopamine in the natriuretic response to volume expansion in rats. Hypertension 1989, 13:828-834.
16. Jose PA, Eisner GM, Felder RA: Renal dopamine and sodium homeostasis. Curr Hypertens Rep 2000, 2:174-183.
17. Bello-Reuss E, Higashi Y, Kaneda Y: Dopamine decreases fluid reabsorption in straight portions of rabbit proximal tubule. Am J Physiol 1982, 242:F634-F640.
18. Aperia A, Bertorello A, Seri I: Dopamine causes inhibition of Na+-K+-ATPase activity in rat proximal convoluted tubule segments. Am J Physiol 1987, 252:F39-F45.
19. Zeng C, Zhang M, Asico LD, et al.: The dopaminergic system in hypertension. Clin Sci (Lond) 2007, 112:583-597.
20. Felder CC, Albrecht FE, Campbell T, et al.: cAMP-independent, G protein-linked inhibition of Na+/H+ exchange in renal brush border by D1 dopamine agonists. Am J Physiol 1993, 264:F1032-171037.
21. Felder CC, Campbell T, Albrecht F, Jose PA: Dopamine inhibits Na(+)-H+ exchanger activity in renal BBMV by stimulation of adenylate cyclase. Am J Pbysiol 1990, 259:F297-F303.
22. Aperia AC: Intrarenal dopamine: a key signal in the interactive regulation of sodium metabolism. Annu Rev Pbysiol 2000, 62:621-647.
23. Horiuchi A, Takeyasu K, Mouradian MM, et al.: D1A dopamine receptor stimulation inhibits Na+/K(+)-ATPase activity through protein kinase A. Mol Pharmacol 1993, 43:281-285.
24. Borin ML: Dual inhibitory effects of dopamine on Na+ homeostasis in rat aorta smooth muscle cells. Am J Physiol 1997, 272:C428-C438.
25. Slobodyansky E, Aoki Y, Gaznabi AK, et al.: Dopamine and protein phosphatase activity in renal proximal tubules. Am J Physiol 1995, 268:F279-F284.
26. Felder CC, McKelvey AM, Gitler MS, et al.: Dopamine receptor subtypes in renal brush border and basolateral membranes. Kidney Int 1989, 36:183-193.
27. Bertorello AM, Aperia A, Walaas SI, et al.: Phosphorylation of the catalytic subunit of Na+,K(+)-ATPase inhibits the activity of the enzyme. Proc Nad Acad Sci U S A 1991, 88:11359-11362.
28. Pedemonte CH, Pressley TA, Cinelli AR, Lokhandwala MF: Stimulation of protein kinase C rapidly reduces intracellular Na+ concentration via activation of the Na+ pump in OK cells. Mol Pharmacol 1997, 52:88-97.
29. Beron J, Forster I, Beguin P, et al.: Phorbol 12-myristate 13-acetate down-regulates Na,K-ATPase independent of its protein kinase C site: decrease in basolateral cell surface area. Mol Biol Cell 1997, 8:387-398.
30. Hussain T, Lokhandwala MF: Altered arachidonic acid metabolism contributes to the failure of dopamine to inhibit Na+,K(+)-ATPase in kidney of spontaneously hypertensive rats. Clin Exp Hypertens 1996, 18:963-974.
31. Chen C, Beach RE, Lokhandwala MF: Dopamine fails to inhibit renal tubular sodium pump in hypertensive rats. Hypertension 1993, 21:364-372.
32. Kansra V, Chen C, Lokhandwala MF: Dopamine causes stimulation of protein kinase C in rat renal proximal tubules by activating dopamine D1 receptors. Eur J Pharmacol 1995, 289:391-394.
33. Yen TT, Yu PL, Roeder H, Willard PW: A genetic study of hypertension in Okamoto-Aoki spontaneously hypertensive rats. Heredity 1974, 33:309-316.
34. Andrejak M, Hary L: Enhanced dopamine renal responsiveness in patients with hypertension. Clin Pharmacol Ther 1986, 40:610-614.
35. O'Connell DP, Ragsdale NV, Boyd DG, et al.: Differential human renal tubular responses to dopamine type 1 receptor stimulation are determined by blood pressure status. Hypertension 1997, 29:115-122.
36. Iimura O, Shimamoto K: Suppressed dopaminergic activity and water-sodium handling in the kidneys at the prehypertensive stage of essential hypertension. J Anton Pharmacol 1990, 10(Suppl 1):S73-S77.
37. Jose PA, Eisner GM, Drago J, et al.: Dopamine receptor signaling defects in spontaneous hypertension. Am J Hypertens 1996, 9:400-405.
38. Zeng C, Sanada H, Watanabe H, et al.: Functional genomics of the dopaminergic system in hypertension. Physiol Genomics 2004, 19:233-246.
39. Nishi A, Eklof AC, Bertorello AM, Aperia A: Dopamine regulation of renal Na+,K(+)-ATPase activity is lacking in Dahl salt-sensitive rats. Hypertension 1993, 21:767-771.
40. Ohbu K, Kaskel FJ, Kinoshita S, Felder RA: Dopamine-1 receptors in the proximal convoluted tubule of Dahl rats: defective coupling to adenylate cyclase. Am J Physiol 1995, 268:R231-R235.
41. Kinoshita S, Sidhu A, Felder RA: Defective dopamine-1 receptor adenylate cyclase coupling in the proximal convoluted tubule from the spontaneously hypertensive rat. J Clin Invest 1989, 84:1849-1856.
42. Horiuchi A, Albrecht FE, Eisner GM, et al.: Renal dopamine receptors and pre- and post-cAMP-mediated Na+ transport defect in spontaneously hypertensive rats. Am J Physiol 1992, 263:F1105-1111.
43. Paravicini TM, Touyz RM: Redox signaling in hypertension. Cardiovasc Res 2006, 71:247-258.
44. Landmesser U, Cai H, Dikalov S, et al.: Role of p47(phox) in vascular oxidative stress and hypertension caused by angiotensin II. Hypertension 2002, 40:511-515.
45. Redon J, Oliva MR, Tormos C, et al.: Antioxidant activities and oxidative stress byproducts in human hypertension. Hypertension 2003, 41:1096-1101.
46. Banday AA, Fazili FR, Lokhandwala MF: Oxidative stress causes renal dopamine D1 receptor dysfunction and hypertension via mechanisms that involve nuclear factorkappaB and protein kinase C. J Am Soc Nepbrol 2007, 18:1446-1457.
47. Banday AA, Lau YS, Lokhandwala MF: Oxidative stress causes renal dopaminc D1 receptor dysfunction and salt-sensitive hypertension in Sprague-Dawley rats. Hypertension 2008, 51:367-375.
48. Banday AA, Marwaha A, Tallam LS, Lokhandwala MF: Tempol reduces oxidative stress, improves insulin sensitivity, decreases renal dopamine D1 receptor hyperphosphorylation, and restores D1 receptor-G-protein coupling and function in obese Zucker rats. Diabetes 2005, 54:2219-2226.
49. Yang Z, Asico LD, Yu P, et al.: D5 dopamine receptor regulation of phospholipase D. Am J Physiol Heart Circ Physiol 2005, 288:H55-H61.
50. Yang Z, Asico LD, Yu P, et al.: D5 dopamine receptor regulation of reactive oxygen species production, NADPH oxidase, and blood pressure. Am J Physiol Regul Integr Comp Physiol 2006, 290:R96-R104.